Centre prohibits selling Coronil as COVID-19 cure

▴ centre-prohibits-selling-coronil-covid19-cure
Ayush ministry has only given the approval to sell this specific formulation as an immunity booster and not as a medicinal remedy for COVID-19.

The Union ministry has banned Patanjali from selling Coronil as a cure for COVID-19.

Ayush ministry has only given the approval to sell this specific formulation as an immunity booster and not as a medicinal remedy for COVID-19, it said.  At a press conference in Haridwar, Ramdev insisted the ministry has said that Patanjali did an appropriate job for COVID-19 management.

 However, on Wednesday Yoga guru Ramdev's Patanjali Ayurved stated that there are no Ayush ministry constraints on selling 'Coronil', a drug the company recently inaugurated as medicine for COVID-19 but is now calling it a product to regulate the disease.

"I want to tell people who want to try these medicines that there is no restriction on their sale now and they will be available in a kit everywhere in the country from today," he added, citing Coronil and the two other products Patanjali is promoting together.

Ramdev told the Union ministry had asked him to use the term 'COVID-19 management' in place of 'COVID-19 treatment' and he is obeying the instruction.

Even while backtracking on characterizing Coronil as a treatment for COVID-19, the company stuck to its statement that the drug's examination on mild to moderately ill patients was successful.

Its press note said the examination, conducted after the necessary permissions, showed 100 percent recovery of patients under seven days.

It started that the Ayush ministry has categorically decided that Patanjali had suitably worked on COVID-19 management.

Now there is no disparity of opinion between Ayush ministry and Patanjali, it added.

According to the ministry, Patanjali is authorized to manufacture and dispense its Diva Coronil tablet, Divya Swasari Vati and Divya Anu Talia across India, as per the manufacturing licences awarded by State Licensing Authority, Ayurvedic and Unani Services, Govt of Uttarakhand, it said.

The Uttarakhand department was among the agencies which had challenged Patanjali's claim to have formulated a drug to cure COVID-19. It said the company had only been given a license to produce an immunity booster

Tags : #Coronil #Patanjali #COVID-19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024
Is Your Daily Turmeric Dose Doing More Harm Than Good: Alarming Lead Levels in Indian TurmericNovember 13, 2024
Moscow Researchers Develop Russia's Pioneer Lumbosacral Spine Phantom for Anesthesia Ultrasound TrainingNovember 12, 2024
World Pneumonia Day: How Pneumonia Continues to Steal Lives and What We Can Do About ItNovember 12, 2024
From Darkness to Clarity: How Stem Cell Transplants Are Offering New Hope for Corneal BlindnessNovember 12, 2024
Daytime Sleepiness and Dementia: Is Napping in the Afternoon Putting You at Risk?November 12, 2024
GET WEDDING-READY WITH KAY BEAUTY: KATRINA KAIF’S TOP PICKS FOR BRIDES & BRIDESMAIDSNovember 11, 2024
Amrita Vishwa Vidyapeetham Students Win Global All-Track Grand Prize at HackHarvard 2024 Organized by Harvard University StudentsNovember 11, 2024
Algorand Foundation Announces its Investment in 5 Startups from the Inaugural Startup Lab Program at T-HubNovember 11, 2024
DOST, DTI & DICT join forces for Philippine Startup Week 2024 to Ignite Filipino InnovationNovember 11, 2024
Firewall gender equality from threats like anti-rights Geneva Consensus DeclarationNovember 11, 2024
Delhi’s Air Crisis: How Toxic Air and Pollution Are Still Threatening Health and Life QualityNovember 11, 2024
Are You at Risk? AI Data Exposes Unseen Triggers of Diabetes in Our EnvironmentNovember 11, 2024
Why Children in High-Risk Areas Are Paying the Price for TB Neglect?November 11, 2024
The Deadly 17: WHO’s Vaccine Priority List to Tackle Life-Threatening InfectionsNovember 09, 2024
Is Your Gut Telling You Something? The Bacterial Clues to Early Rheumatoid ArthritisNovember 09, 2024